Angela Kashuba is the Dean of the University of North Carolina at Chapel Hill Eshelman School of Pharmacy. She is the John A. and Deborah S. McNeill Jr. Distinguished Professor of Pharmacy, Chair of the Division of Pharmacotherapy and Experimental Therapeutics,[1] and Director of the UNC CFAR Clinical Pharmacology and Analytical Chemistry Core.[2][3]
Angela D. Kashuba, PharmD | |
|---|---|
| Alma mater | University of Toronto, University at Buffalo |
| Known for | Antiretroviral Pharmacology |
| Website | https://pharmacy.unc.edu/angela-kashuba-lab/ |
Education and career
editKashuba received her Bachelors of Pharmacy from University of Toronto and her Doctorate of Pharmacy from University at Buffalo School of Pharmacy and Pharmaceutical Sciences. She next completed residency at Women's College Hospital in Toronto. After her residency, she studied clinical pharmacology at Bassett Healthcare, which is part of Columbia University Medical Center.[2][4]
The focus of Kashuba's research career has been pharmacology of antiretrovirals for the treatment and prevention of HIV.[2][5][4][6][7]
Recognition
editIn 2009, Kashuba received the Leon I. Goldberg Young Investigator Award from the American Society for Pharmacology and Experimental Therapeutics.[4]
Personal life
editShe has two children and notes the individuality of work–life balance.[5]
References
edit- ^ "University of North Carolina at Chapel Hill Pharmacotherapy and Experimental Therapeutics". PharmGrad. Retrieved 6 August 2018.
- ^ a b c "ANGELA KASHUBA, PHARMD". Virology Education. Retrieved 6 August 2018.
- ^ "CLINICAL PHARMACOLOGY AND ANALYTICAL CHEMISTRY CORE". UNC CFAR. Retrieved 6 August 2018.
- ^ a b c "Angela D.M. Kashuba, BScPhm, PharmD, DABCP". antimicrobe.org. Retrieved 6 August 2018.
- ^ a b Laura, Hoopes. "Angela Kashuba featured in NIH Women in Science Update". Nature.com. Retrieved 6 August 2018.
- ^ Pope, R Jr; Kashuba, A (December 2017). "Darunavir for use in pregnant women with HIV". Expert Rev Clin Pharmacol. 10 (12): 1317–1327. doi:10.1080/17512433.2017.1390428. PMID 28988509. S2CID 31650716.
- ^ Cottrell, ML; Srinivas, N; Kashuba, A (June 2015). "Pharmacokinetics of antiretrovirals in mucosal tissue". Expert Opin Drug Metab Toxicol. 11 (6): 893–905. doi:10.1517/17425255.2015.1027682. PMC 4498566. PMID 25797064.